Physician

Babafemi Babawande Pratt, MD, MPH

According to 2025 Medicare claims, Babafemi Pratt, MD, MPH (NPI: 1174773873) practices vascular surgery in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is NIRP DALLAS-FORT WORTH PLLC (NPI: 1992260277; TIN: 832477750) and primary practice location at 76021-8228. Pratt is affiliated with the CommonSpirit ACO I (ACO ID: A2164), Mercy Health ACO, LLC (ACO ID: A2616), Aledade A2643 Primary Care MSSP Enhanced (ACO ID: A2643), and Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Pratt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 79 traditional Medicare patients, billed 5,356 HCPCS/CPT codes, and received $547,048 in Medicare payments. The top billing code was 37229 (Removal of plaque in artery of leg, initial vessel). Part D data shows 179 prescription claims across 85 beneficiaries totaling $16,626 in drug costs, led by Clopidogrel (Clopidogrel Bisulfate). 2023 DME data shows 66 claims. Open Payments data shows 15 records totaling $802. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $174 to $16,626. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	111	469	$81,941
2018	132	398	$72,612
2019	177	802	$116,794
2020	124	1,352	$908,637
2021	209	2,825	$3,464,780
2022	145	1,539	$1,499,197
2023	128	705	$492,203
2024	79	5,356	$547,048

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	17	24	$174
2016	39	54	$1,179
2017	55	111	$2,676
2018	66	136	$9,456
2019	76	207	$11,695
2020	55	91	$4,354
2021	159	360	$15,633
2022	159	480	$58,628
2023	82	238	$43,341
2024	85	179	$16,626

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	66	$12,870
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
37229	Removal of plaque in artery of leg, initial vessel	27	43	$6,128
37252	Ultrasound evaluation of blood vessel with review by radiologist, initial vessel	30	47	$729
37253	Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel	30	62	$134
76937	Ultrasonic guidance for blood vessel access	31	53	$30
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	31	4,873	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Clopidogrel	Clopidogrel Bisulfate	70	5,635	$554
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	145	$288
Diclofenac Sodium	Diclofenac Sodium	11	177	$275
Methocarbamol	Methocarbamol	14	141	$83

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$802	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Babafemi Babawande Pratt, MD, MPH?

Tedicare shows public-source Medicare data for Babafemi Babawande Pratt, MD, MPH (NPI 1174773873), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Babafemi Babawande Pratt, MD, MPH have ACO affiliation data?

Babafemi Babawande Pratt, MD, MPH is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164), Mercy Health ACO, LLC (MSSP, ACO ID A2616), Aledade A2643 Primary Care MSSP Enhanced (MSSP, ACO ID A2643), and Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Babafemi Babawande Pratt, MD, MPH?

Babafemi Babawande Pratt, MD, MPH is linked to NIRP DALLAS-FORT WORTH PLLC (billing NPI 1992260277) in the available physician profile data.

Does Babafemi Babawande Pratt, MD, MPH have Open Payments data?

Babafemi Babawande Pratt, MD, MPH has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.